Group 1 - The core viewpoint of the article highlights the listing of new stocks on December 2, with E Ausaitou and Jingchuang Electric being the two companies mentioned [1][3][4] - E Ausaitou, listed on the Sci-Tech Innovation Board, has an issuance price of 26.68 yuan and a total market value of 10.66 billion yuan, with a high issuance price-to-earnings ratio of 519.12 [2] - The company is recognized as one of the first entrants in the gene editing field in China, possessing a leading technological advantage and becoming a giant in the domestic model organism sector [2] - E Ausaitou has established relationships with the top ten global pharmaceutical companies based on projected 2024 revenues, indicating strong industry connections [2] - The company is actively developing an antibody discovery platform leveraging its gene editing advantages, focusing on TCR mouse platform biotechnology [2] Group 2 - Jingchuang Electric, listed on the Beijing Stock Exchange, has an issuance price of 17.10 yuan and a total market value of 525 million yuan, with a more modest issuance price-to-earnings ratio of 13.47 [4] - The company specializes in the research, production, and sales of smart controllers for cold chain equipment, as well as environmental particle detection instruments [4] - In 2023, Jingchuang Electric achieved a leading market share in the cold chain temperature and humidity control sector in China [4]